Internal Medicine, Infectious Disease · Lawrence, KS
NPI
1992702492
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4525 W 6th St, Suite 100
Lawrence, KS, 66049
Phone (785) 505-5160
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
2,420 services
Medicare patients, 2024
328
Average age 73
Drug cost, 2024
$1.3M
1,592 prescriptions
Company payments, 2025
$12.42
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher C Penn was code 99214 (office e&m - established), 180 times for 115 patients. In total Christopher C Penn billed 2,420 services in 31 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 180 | 115 | $84.21 | $15K |
| 99231 Hospital E&M - Subsequent | Facility | 135 | 84 | $36.70 | $4,955 |
| 36415 Venipuncture Blood Collection | Office | 93 | 70 | $8.65 | $804 |
| 99213 Office E&M - Established | Office | 84 | 63 | $58.93 | $4,950 |
| 99232 Hospital E&M - Subsequent | Facility | 74 | 47 | $58.66 | $4,341 |
| 99222 Hospital E&M - Initial | Facility | 59 | 58 | $96.91 | $5,718 |
| 99215 Office E&M - Established | Office | 41 | 36 | $123.28 | $5,054 |
| 99205 Office E&M - New | Office | 39 | 39 | $155.40 | $6,061 |
| 99204 Office E&M - New | Office | 39 | 39 | $117.58 | $4,586 |
| 99223 Hospital E&M - Initial | Facility | 35 | 35 | $128.37 | $4,493 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 13 | $12.35 | $185 |
By year: 2022 $713K for 86,208 services; 2023 $569K for 21,607 services; 2024 $88K for 2,420 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 93 | 70 | $8.65 | $804 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher C Penn prescribed most often to Medicare patients was Cephalexin, with 154 prescriptions and refills. In total Christopher C Penn wrote 1,592 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 154 | 182 | 30 | $1,945 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 143 | 143 | 112 | $29K |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 131 | 131 | 131 | $39K |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 118 | 118 | 118 | $7,599 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 81 | 81 | Under 11 | $343K |
| Doxycycline Hyclate Generic | 66 | 90 | 27 | $2,136 |
| Methenamine Hippurate Generic | 48 | 70 | 13 | $2,922 |
| Levofloxacin Generic | 47 | 47 | 29 | $301 |
| Juluca Dolutegravir/Rilpivirine | 45 | 45 | Under 11 | $168K |
| Cefdinir Generic | 44 | 60 | 21 | $1,527 |
| Fluconazole Generic | 40 | 46 | 19 | $950 |
| Amoxicillin Generic | 38 | 52 | Under 11 | $187 |
| Pifeltro Doravirine | 33 | 33 | Under 11 | $64K |
| Dovato Dolutegravir Sodium/Lamivudine | 32 | 34 | Under 11 | $101K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 29 | 29 | Under 11 | $114K |
Brand drugs: 749 claims; generic drugs: 843 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher C Penn $12.42 ($12.42 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $12.42.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $12.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.